To prevent this, it is important to have regular meals and always carry a fast-acting source of glucose, such as sugary candy or glucose candy, with you
14.3 Weight Reduction and Long-term Maintenance Study of WEGOVY Injection in Pediatric Patients Aged 12 Years and Older with Obesity Overview of Clinical Trial in Pediatric Patients WEGOVY injection was evaluated to reduce excess body weight in pediatric patients aged 12 years of age and older with obesity in a 68-week, double-blind, randomized, parallel group, placebo-controlled, multi-center trial in 201 pubertal pediatric patients aged 12 years and older with BMI corresponding to 95th percentile standardized for age and sex (Study 10) (NCT#04102189)
These medications should generally be avoided in patients with a history of pancreatitis
History of pancreatitis or gallbladder disease: Use is discouraged because these medications can increase risk
diet, youre working with a team that understands the complexities of weight management and uses evidence-based methods to guide you
Answer a few questions about your health history, current goals, and any symptoms you may be experiencing
